ecancer

Engineering of polymeric nanoparticles for medical applications

Dr Omid Farokhzad - Harvard Medical School, Boston, USA

14 Nov 2013

PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer

Dr Chris Gallagher - Barts and the London NHS Trust, UK

12 Nov 2013

Future perspectives: realising the potential of personalised healthcare in gynaecological cancer

Dr Jonathan Ledermann - University College London, United Kingdom

8 Nov 2013

The revolution in personalised healthcare: Towards improved outcomes in oncology: Conclusion and Summary

Dr Frances Shepherd - Princess Margaret Hospital and the University of Toronto, Canada

8 Nov 2013

Advances in geriatric, medical oncology

Prof Stuart Lichtman - Memorial Sloan Kettering Cancer Center, New York, USA

7 Nov 2013

Follow up study on the effect of chemotherapy in pregnant women

Prof Fredric Amant - University of Leuven, Belgium

1 Nov 2013

Results from the TRINOVA 1 trial

Prof Bradley Monk - Creighton University School of Medicine, USA

1 Nov 2013

Clinical trials, ENGOT and use of bevacizumab against angiogenesis

Prof Christian Marth - Innsbruck Medical University, Austria

1 Nov 2013

Emerging sentinel node in cervical cancer

Prof David Cibula - Charles University Hospital, Prague, Czech Republic

1 Nov 2013

Selecting treatment methods for cervical cancer

Prof Denis Querleu - Claudius Regaud Cancer Center and University of Toulouse, France

1 Nov 2013

Results of the ICON7, phase III clinical trial

Prof Eric Pujade-Lauraine - Université de Paris Descartes, France

1 Nov 2013

Overview of the 2013 ESGO scientific programme

Prof John Green – University of Liverpool, UK

31 Oct 2013

More from ecancer